Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program
Go back to Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 152.57 -0.36 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.93 | 52 Week High | $58.46 | |||
| Open | $153.13 | 52 Week Low | $31.25 | |||
| Day High | $155.27 | P/E | N/A | |||
| Day Low | $152.51 | EPS | $-0.69 | |||
| Volume | 1,227,622 | |||||
| (NASDAQ: VYGR) | Delayed: 3.39 +0.07 (2.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.32 | 52 Week High | $30.54 | |||
| Open | $3.36 | 52 Week Low | $8.12 | |||
| Day High | $3.44 | P/E | N/A | |||
| Day Low | $3.30 | EPS | $0.00 | |||
| Volume | 424,439 | |||||
